These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11499983)

  • 1. Fetal DNA in maternal plasma: application to non-invasive blood group genotyping of the fetus.
    Lo YM
    Transfus Clin Biol; 2001 Jun; 8(3):306-10. PubMed ID: 11499983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.
    Lo YM
    Transfus Clin Biol; 2006; 13(1-2):50-2. PubMed ID: 16563836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive antenatal RHD typing.
    Van der Schoot CE; Soussan AA; Koelewijn J; Bonsel G; Paget-Christiaens LG; de Haas M
    Transfus Clin Biol; 2006; 13(1-2):53-7. PubMed ID: 16564727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal genotyping of RHD and SRY using maternal blood.
    Randen I; Hauge R; Kjeldsen-Kragh J; Fagerhol MK
    Vox Sang; 2003 Nov; 85(4):300-6. PubMed ID: 14633256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fetal RHD genotyping by PCR using plasma from D negative pregnant women].
    Achargui S; Tijane M; Benchemsi N
    Transfus Clin Biol; 2011 Feb; 18(1):13-9. PubMed ID: 21190884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal genotyping of the blood groups of the fetus.
    Avent ND
    Vox Sang; 1998; 74 Suppl 2():365-74. PubMed ID: 9704469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of fetal Rh D and Rh CcEe phenotype from maternal plasma with real-time polymerase chain reaction.
    Legler TJ; Lynen R; Maas JH; Pindur G; Kulenkampff D; Suren A; Osmers R; Köhler M
    Transfus Apher Sci; 2002 Dec; 27(3):217-23. PubMed ID: 12509216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal RhD genotyping from maternal plasma.
    Lo YM
    Ann Med; 1999 Oct; 31(5):308-12. PubMed ID: 10574502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
    Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
    Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Noninvasive prenatal diagnosis from maternal plasma in serological conflicts in Poland: current practice and future prospects].
    Orzińska A; Guz K; Brojer E
    Ginekol Pol; 2009 Oct; 80(10):768-71. PubMed ID: 19943542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G; Finning K; Martin P; Soothill P
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genotyping in transfusion medicine.
    Westhoff CM; Sloan SR
    Clin Chem; 2008 Dec; 54(12):1948-50. PubMed ID: 18927242
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular blood grouping.
    Daniels G
    Vox Sang; 2004 Jul; 87 Suppl1():63-6. PubMed ID: 15200607
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
    Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
    N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasma.
    Scheffer PG; de Haas M; van der Schoot CE
    Curr Opin Hematol; 2011 Nov; 18(6):467-73. PubMed ID: 21926618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiplex PCR for non-invasive fetal RHD genotyping using cell-free fetal DNA.
    Tounta G; Vrettou C; Kolialexi A; Papantoniou N; Destouni A; Tsangaris GT; Antsaklis A; Kanavakis E; Mavrou A
    In Vivo; 2011; 25(3):411-7. PubMed ID: 21576416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan.
    Mohammed N; Kakal F; Somani M; Zafar W
    J Coll Physicians Surg Pak; 2010 Apr; 20(4):246-9. PubMed ID: 20392400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups.
    Doescher A; Petershofen EK; Wagner FF; Schunter M; Müller TH
    Transfusion; 2013 Feb; 53(2):353-62. PubMed ID: 22691192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.